NCT02462811 · Interventional trial
A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)
Overall registry status Completed
Phase 3
Conditions Nausea, Pain, Vomiting
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory